NOVEL GLUTAMINE ANTAGONISTS AND USES THEREOF

Glutamine antagonists and their use for treating oncological, immunological, and neurological diseases are disclosed. Also disclosed are methods for treating an oncological, immunological, infectiousor neurological disease or disorder, the method comprising administering to a subject in need of trea...

Full description

Saved in:
Bibliographic Details
Main Authors NOVOTNA KATERINA, TENORA LUKAS, SLUSHER BARBARA, MAJER PAVEL, RAIS RANA, ALT JESSE
Format Patent
LanguageChinese
English
Published 21.08.2020
Subjects
Online AccessGet full text

Cover

More Information
Summary:Glutamine antagonists and their use for treating oncological, immunological, and neurological diseases are disclosed. Also disclosed are methods for treating an oncological, immunological, infectiousor neurological disease or disorder, the method comprising administering to a subject in need of treatment thereof a therapeutically effective amount of a glutamine antagonist of the disclosure or thepharmaceutical composition thereof. Also disclosed are methods of enhancing the effects of an immune checkpoint inhibitor, enabling a subject to respond to an immune checkpoint inhibitor, or enablingthe toxicity or the dose or number of treatments with an immune checkpoint inhibitor to be reduced, comprising administering to a subject in need of treatment thereof a therapeutically effective amount of a glutamine antagonist of the disclosure or the pharmaceutical composition thereof, and an immune checkpoint inhibitor. Also disclosed are methods for treating an oncological, immunological, infectious or neurological dis
Bibliography:Application Number: CN20188079030